Proteoglycan production in disomic and trisomy 7-carrying human synovial cells.
To gain further insight into the synthesis and structure of the synovial matrix of joints, we have established cell cultures from synovial specimens and elaborated their production of hyaluronan and proteoglycans. The cultures secreted mainly the small proteoglycan decorin, but also considerable amounts of the related biglycan and the large proteoglycan versican. Only minor amounts of heparan sulfate proteoglycans were found. All cultures also had a high production of hyaluronan, which highlights the important role for normal joint function of these cells. In joint diseases, a common feature is the presence of an extra chromosome 7 (trisomy 7) in the synovial cells. To study the possible consequences of trisomy 7 on the synovial cell function, we extended our study to cultures that had been sub-cloned to contain high amounts of trisomy 7-carrying cells. These cell cultures had approximately four times more versican than their disomic counterparts in the cell culture medium, indicating that versican may be a mediator in the processes of joint destructive disorders. To find an explanation for this increase in versican, we investigated the expression/secretion of PDGF-AA and IL-6, cytokines with their genes located to chromosome 7. Indeed, both these cytokines were increased in the cultures with high frequencies of trisomy 7. We then added the two cytokines to cell cultures of disomic synovial cells, but only cells treated with IL-6 displayed an increased amount of versican. Thus, we suggest that the increased amount of versican in cultures of trisomy 7-carrying cells relates to an autocrine loop involving an increased IL-6 production.
Eklund
Erik
E
Department of Cell and Molecular Biology, Sec f Cell and Matrix Biology, Lund University, BMC C13, S-221 84, Lund, Sweden. erik.eklund@medkem.lu.se
Broberg
Karin
K
Westergren-Thorsson
Gunilla
G
Bjärdahlen
Anette
A
Hedlund
Maria
M
Malmström
Anders
A
D002478:Cells, Cultured; D011508:Chondroitin Sulfate Proteoglycans / Q000096:biosynthesis / Q000378:metabolism; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics*; D006801:Humans; D006820:Hyaluronic Acid / Q000096:biosynthesis; D017404:In Situ Hybridization, Fluorescence; D015850:Interleukin-6 / Q000378:metabolism; D037181:Lectins, C-Type; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D011509:Proteoglycans / Q000096:biosynthesis* / Q000378:metabolism; D013582:Synovial Fluid / Q000378:metabolism; D013583:Synovial Membrane / Q000166:cytology* / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis / Q000235:genetics; D014314:Trisomy / Q000235:genetics*; D053675:Versicans
D011508:Chondroitin Sulfate Proteoglycans; D015850:Interleukin-6; D037181:Lectins, C-Type; D010982:Platelet-Derived Growth Factor; D011509:Proteoglycans; D016212:Transforming Growth Factor beta; C508322:VCAN protein, human; C075278:platelet-derived growth factor A; D053675:Versicans; D006820:Hyaluronic Acid